Some immune-boosting cancer drugs may pose rare heart risks

Some immune-boosting cancer drugs may pose rare heart risks


Doctors have found a disturbing downside to some powerful new drugs that harness the immune system to fight cancer: In rare cases, they may cause potentially fatal heart damage, especially when used together. "The problem is, no one has this on their radar," so patients are not routinely checked for it, said Dr. Javid Moslehi, head of a Vanderbilt University clinic specializing in heart risks from cancer therapies.



from Biotech News